About this trial

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Eligibility criteria

Qualifiers

Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy

Willingness to sign an Informed Consent Document or verbally agree to participation

Disqualifiers

There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

Trial design

Treatments tested in this trial

  • SRS/SBRT

Treatment groups

50,000 Participants
are divided into 1 treatment group

Locations

13
Colorado
Penrose Cancer Center80907, Colorado Springs United States
Florida
Sylvester Comprehensive Cancer Center, University of Miami33146, Miami United States
Georgia
Southeast Georgia Health System31520, Brunswick United States
Michigan
Henry Ford Health System48202, Detroit United States

Sponsors and collaborators

The Radiosurgery Society

Lead sponsor

VisionTree

Collaborator